Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hayato Orui"'
Autor:
Sumie Yamamoto, Yoshihiro Suzuki, Takushi Sato, Shuko Takahashi, Takashi Yorifuji, Hideki Hayashi, Hayato Orui, Hiroshi Sashiyama, Shigeru Suganami, Taro Hasegawa, Taro Sakai, Toru Yoneda, Maki Okamoto, Daisuke Kato, Yoshiomi Kishida
Publikováno v:
Archives of Environmental & Occupational Health. 73:284-291
Two huge earthquakes struck Kumamoto, Japan, in April 2016, forcing residents to evacuate. Few studies have reported early-phase disease and injury trends among evacuees following major inland earthquakes. We evaluated the trends among evacuees who v
Autor:
Kanako Kumamoto, Kazue Yoneda, Akramul Haque, Nobuyuki Kondo, Golam Mohiuddin Akbar Chowdhury, Yoshitomo Okumura, Fumihiro Tanaka, Masaki Hashimoto, Hayato Orui, Seiki Hasegawa, Mohammad Golam Mostafa, Teruhisa Takuwa, Shakibur Rahman
Publikováno v:
International Journal of Clinical Oncology. 19:45-49
Worldwide studies on lung adenocarcinoma have demonstrated a genetic divergence of the epidermal growth factor receptor (EGFR) pathway according to ethnicity, such as higher frequency of activated EGFR mutations among East Asian patients. However, su
Autor:
Fumihiro Tanaka, Kozo Kuribayashi, Seiji Matsumoto, Takashi Nakano, Seiki Hasegawa, Noriaki Tsubota, Yoshitomo Okumura, Masaki Hashimoto, Teruhisa Takuwa, Hayato Orui, Kazuya Fukuoka, Kazue Yoneda, Nobuyuki Kondo, Ayuko Sato, Tohru Tsujimura
Publikováno v:
Annals of surgical oncology. 19(13)
The purpose of this study was to investigate the diagnostic and prognostic value of circulating endothelial cell (CEC), a potential surrogate of tumor angiogenesis, in malignant pleural mesothelioma (MPM). We prospectively evaluated CEC count in 4.0
Autor:
Hayato Orui, Kazue Yoneda, Nobuyuki Kondo, Takashi Nakano, Ikuko Torii, Yoshitomo Okumura, Teruhisa Takuwa, Noriaki Tsubota, Seiki Hasegawa, Tohru Tsujimura, Shunichi Fukuda, Seiji Matsumoto, Masaki Hashimoto, Kazuya Fukuoka
Publikováno v:
International journal of clinical oncology. 17(1)
Malignant pleural mesothelioma (MPM) remains suffering poor prognosis in spite of recent diagnostic and therapeutic progress. Although there is currently no established evidence, early diagnosis and early intervention may play a key role to improve p
Autor:
Seiji Matsumoto, Masaki Hashimoto, Kazue Yoneda, Nobuyuki Kondo, Ayumi Kuroda, Hayato Orui, Teruhisa Takuwa, Seiki Hasegawa
Publikováno v:
Journal of Clinical Oncology. 31:e18557-e18557
e18557 Background: Malignant pleural mesothelioma (MPM) is an aggressive tumor and poor prognosis. Active new agents is an urgent priority for patients with MPM. PI3K/AKT/mTOR pathway inhibitors in MPM have reported, but, the results has limited. Bec
Autor:
Teruhisa Takuwa, Masaki Hashimoto, Kazuya Fukuoka, Seiki Hasegawa, Hayato Orui, Yoshitomo Okumura, Tohru Tsujimura, Seiji Matsumoto, Ayuko Sato, Noriaki Tsubota, Takashi Nakano, Kazue Yoneda, Nobuyuki Kondo, Shunichi Fukuda, Fumihiro Tanaka
Publikováno v:
Journal of Clinical Oncology. 30:7080-7080
7080 Background: Circulating tumor cell (CTC) is a surrogate of distant metastasis, and our preliminary study suggested that CTC detected by an EpCAM-based immuno-magnetic separation system (“CellSearch”) was a useful clinical marker in the diagn
Autor:
Tohru Tsujimura, Yoshitomo Okumura, Seiji Matsumoto, Masaki Hashimoto, Kazuya Fukuoka, Teruhisa Takuwa, Seiki Hasegawa, Hayato Orui, Kazue Yoneda, Nobuyuki Kondo, Fumihiro Tanaka, Ikuko Torii, Takashi Nakano
Publikováno v:
Journal of Clinical Oncology. 29:e21095-e21095
e21095 Background: Pleural effusion cytology is sometimes insufficient to diagnose Malignant Pleural Mesothelioma (MPM) and pleural biopsy is essential for definitively diagnosis. In this study, we...
Autor:
Seiki Hasegawa, Yoshitomo Okumura, Takashi Nakano, Teruhisa Takuwa, Kazuya Fukuoka, K. Kuribayashi, Ayuko Sato, Noriaki Tsubota, Hayato Orui, Seiji Matsumoto, Fumihiro Tanaka, Masaki Hashimoto, Kazue Yoneda, Nobuyuki Kondo, Tohru Tsujimura
Publikováno v:
Journal of Clinical Oncology. 29:10577-10577
10577 Background: Circulating endothelial cell (CEC) is a potential surrogate of tumor angiogenesis, but the clinical value in malignant pleural mesothelioma (MPM) remains unknown. Methods: Patient...